By using luciferase reporter assay we validated that CDH2 and Golm-1 are miR-145-5p target genes also in the Thymic Carcinoma cell lines TC1889, as already published, respectively, for gastric [48] and prostate cancer [50]. This evidence concerns the gene CDH2 and prostate cancer.